Literature DB >> 2909919

Experimental meningeal carcinomatosis selectively depresses local cerebral glucose utilization in rat brain.

E M Hiesiger1, A Picco-Del Bo, L E Lipschutz, G A Basler, H T Thaler, J B Posner, W R Shapiro.   

Abstract

Using quantitative autoradiography, we investigated the effect of meningeal carcinomatosis on local cerebral glucose utilization (LCGU). A rat model of meningeal carcinomatosis using Walker 256 tumor was used. LCGU was evaluated using 14C-2-deoxy-D-glucose according to the Sokoloff method. Thirty-one neuroanatomic structures were evaluated, both separately and as part of five functional or neuroanatomic groups: olfactory, auditory, visual, limbic, and white matter. The relationship between tumor and LCGU of underlying brain was examined. Compared with controls, there was no global change of LCGU in the experimental group that applied to all structures. However, mean LCGU was significantly depressed in olfactory cortex, temporal cortex, olfactory tubercle, amygdala, caudate/putaman, inferior colliculus, medial geniculate, anterior commissure, and corpus callosum, and the functional groups that make up the olfactory and auditory systems. There was no correlation between extent of regional tumor burden and degree of depression of LCGU in underlying structures. In meningeal carcinomatosis, tumor results in selective regional depression of LCGU. This occurs both in structures underlying tumor and those anatomically remote, but in certain cases, functionally related to structures subadjacent to tumor. These data may help to explain the diversity of neurologic dysfunction seen in patients with meningeal cancer.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2909919     DOI: 10.1212/wnl.39.1.90

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  Meningeal carcinomatosis.

Authors:  W R Shapiro
Journal:  West J Med       Date:  1991-03

Review 2.  In situ hybridization: a possible diagnostic aid in leptomeningeal metastasis.

Authors:  R J van Oostenbrugge; A H Hopman; F C Ramaekers; A Twijnstra
Journal:  J Neurooncol       Date:  1998 Jun-Jul       Impact factor: 4.130

Review 3.  Animal models of leptomeningeal metastasis.

Authors:  M Schabet; U Herrlinger
Journal:  J Neurooncol       Date:  1998 Jun-Jul       Impact factor: 4.130

Review 4.  Leptomeningeal metastases from solid malignancy: a review.

Authors:  Sophie Taillibert; Florence Laigle-Donadey; Catherine Chodkiewicz; Marc Sanson; Khê Hoang-Xuan; Jean-Yves Delattre
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

5.  Leptomeningeal metastasis as initial manifestation of signet ring colorectal adenocarcinoma: a case report with review of literature.

Authors:  Rita Assi; Lana Hamieh; Deborah Mukherji; Ali Haydar; Sally Temraz; Imane El-Dika; Ali Shamseddine
Journal:  J Gastrointest Oncol       Date:  2015-12

Review 6.  Meningeal carcinomatosis as the first manifestation of a transitional cell carcinoma of the bladder.

Authors:  Jordi Bruna; Iñigo Rojas-Marcos; Sergio Martínez-Yelamos; Isabel Català; Antonio Vidaller; Carmen Galán; Jurek Krupinski; Francisco Rubio
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

7.  An experimental model of leptomeningeal metastases employing rat mammary carcinoma cells.

Authors:  S M Sagar; K J Price
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 8.  'Hot cross bun' sign with leptomeningeal metastases of breast cancer: a case report and review of the literature.

Authors:  Zhenyu Pan; Guozi Yang; Tingting Yuan; Yongxiang Wang; Xiaochuan Pang; Yan Gao; Lihua Dong
Journal:  World J Surg Oncol       Date:  2015-02-12       Impact factor: 2.754

9.  Carcinomatous meningitis: Leptomeningeal metastases in solid tumors.

Authors:  Emilie Le Rhun; Sophie Taillibert; Marc C Chamberlain
Journal:  Surg Neurol Int       Date:  2013-05-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.